Download | < Back |
08 Jan 2016 | |
Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated January 08, 2016 titled "Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel bi-specific monoclonal antibody targeting CD38". | |
View all announcements for GLENMARK PHARMACEUTICALS LTD. | Source: BSE India |